Provided by Tiger Trade Technology Pte. Ltd.

Charles Schwab

114.26
+1.961.75%
Volume:494.51K
Turnover:56.12M
Market Cap:197.56B
PE:20.81
High:114.31
Open:113.25
Low:112.51
Close:112.30
52wk High:114.31
52wk Low:83.96
Shares:1.73B
Float Shares:1.58B
Volume Ratio:1.20
T/O Rate:0.03%
Dividend:1.23
Dividend Rate:1.08%
EPS(TTM):5.49
EPS(LYR):4.67
ROE:20.27%
ROA:2.07%
PB:4.50
PE(LYR):24.49

Loading ...

Jan 31, 2020

Major Issues Report

Current report, item 5.02
Jan 30, 2020

Business Combinations

Prospectuses and communications, business combinations
Jan 29, 2020

Major Issues Report

Current report, item 8.01
Jan 29, 2020

Business Combinations

Prospectuses and communications, business combinations
Jan 16, 2020

Major Issues Report

Current report, items 2.02 and 9.01
Dec 06, 2019

Business Combinations

Prospectuses and communications, business combinations
Dec 04, 2019

Beneficial Ownership Change

General statement of acquisition of beneficial ownership
Nov 29, 2019

Business Combinations

Prospectuses and communications, business combinations
Nov 29, 2019

Major Issues Report

Current report, items 1.01 and 9.01
Nov 29, 2019

Beneficial Ownership Change

[Amend] General statement of acquisition of beneficial ownership
Nov 26, 2019

Business Combinations

Prospectuses and communications, business combinations
Nov 25, 2019

Major Issues Report

Current report, items 8.01 and 9.01
Nov 25, 2019

Business Combinations

Prospectuses and communications, business combinations
Nov 25, 2019

Business Combinations

Prospectuses and communications, business combinations
Nov 25, 2019

Business Combinations

Prospectuses and communications, business combinations
Nov 25, 2019

Business Combinations

Prospectuses and communications, business combinations
Nov 25, 2019

Business Combinations

Prospectuses and communications, business combinations
Nov 07, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
Oct 15, 2019

Major Issues Report

Current report, items 2.02 and 9.01
Aug 28, 2019

Major Issues Report

Current report, items 5.02 and 9.01